PT  - JOURNAL ARTICLE
AU  - Shuai Wang
AU  - Bo Kang
AU  - Jinlu Ma
AU  - Xianjun Zeng
AU  - Mingming Xiao
AU  - Jia Guo
AU  - Mengjiao Cai
AU  - Jingyi Yang
AU  - Yaodong Li
AU  - Xiangfei Meng
AU  - Bo Xu
TI  - A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)
AID  - 10.1101/2020.02.14.20023028
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.14.20023028
4099  - http://medrxiv.org/content/early/2020/04/24/2020.02.14.20023028.short
4100  - http://medrxiv.org/content/early/2020/04/24/2020.02.14.20023028.full
AB  - Background The outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) has caused more than 2.5 million cases of Corona Virus Disease (COVID-19) in the world so far, with that number continuing to grow. To control the spread of the disease, screening large numbers of suspected cases for appropriate quarantine and treatment is a priority. Pathogenic laboratory testing is the gold standard but is time-consuming with significant false negative results. Therefore, alternative diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we hypothesized that Artificial Intelligence’s deep learning methods might be able to extract COVID-19’s specific graphical features and provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control.Methods and Findings We collected 1,065 CT images of pathogen-confirmed COVID-19 cases (325 images) along with those previously diagnosed with typical viral pneumonia (740 images). We modified the Inception transfer-learning model to establish the algorithm, followed by internal and external validation. The internal validation achieved a total accuracy of 89.5% with specificity of 0.88 and sensitivity of 0.87. The external testing dataset showed a total accuracy of 79.3% with specificity of 0.83 and sensitivity of 0.67. In addition, in 54 COVID-19 images that first two nucleic acid test results were negative, 46 were predicted as COVID-19 positive by the algorithm, with the accuracy of 85.2%.Conclusion These results demonstrate the proof-of-principle for using artificial intelligence to extract radiological features for timely and accurate COVID-19 diagnosis.Author summary To control the spread of the COVID-19, screening large numbers of suspected cases for appropriate quarantine and treatment measures is a priority. Pathogenic laboratory testing is the gold standard but is time-consuming with significant false negative results. Therefore, alternative diagnostic methods are urgently needed to combat the disease. We hypothesized that Artificial Intelligence’s deep learning methods might be able to extract COVID-19’s specific graphical features and provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time. We collected 1,065 CT images of pathogen-confirmed COVID-19 cases along with those previously diagnosed with typical viral pneumonia. We modified the Inception transfer-learning model to establish the algorithm. The internal validation achieved a total accuracy of 89.5% with specificity of 0.88 and sensitivity of 0.87. The external testing dataset showed a total accuracy of 79.3% with specificity of 0.83 and sensitivity of 0.67. In addition, in 54 COVID-19 images that first two nucleic acid test results were negative, 46 were predicted as COVID-19 positive by the algorithm, with the accuracy of 85.2%. Our study represents the first study to apply artificial intelligence to CT images for effectively screening for COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available. https://ai.nscc-tj.cn/thai/deploy/public/pneumonia_ct COVID-19Corona Virus DiseaseCTComputed TomographySARS-COV-2severe acute respiratory syndrome coronavirus 2ConvolutionalCNNNeural NetworkROIregion of interestM-Inceptionmodified InceptionAUCArea Under CurvePPVPositive predictive valueNPVNegative predictive valueCVcomputer vision